APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 38 filers reported holding APPLIED DNA SCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,000 | -55.6% | 36,200 | 0.0% | 0.00% | – |
| Q2 2019 | $18,000 | -30.8% | 36,200 | 0.0% | 0.00% | – |
| Q1 2019 | $26,000 | +85.7% | 36,200 | 0.0% | 0.00% | – |
| Q4 2018 | $14,000 | -74.1% | 36,200 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | +17.4% | 36,200 | 0.0% | 0.00% | – |
| Q2 2018 | $46,000 | -11.5% | 36,200 | 0.0% | 0.00% | – |
| Q1 2018 | $52,000 | -10.3% | 36,200 | 0.0% | 0.00% | – |
| Q4 2017 | $58,000 | -44.2% | 36,200 | 0.0% | 0.00% | – |
| Q3 2017 | $104,000 | +62.5% | 36,200 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | +6.7% | 36,200 | 0.0% | 0.00% | – |
| Q1 2017 | $60,000 | -10.4% | 36,200 | 0.0% | 0.00% | – |
| Q4 2016 | $67,000 | -39.6% | 36,200 | 0.0% | 0.00% | – |
| Q3 2016 | $111,000 | -5.1% | 36,200 | 0.0% | 0.00% | – |
| Q2 2016 | $117,000 | -6.4% | 36,200 | 0.0% | 0.00% | – |
| Q1 2016 | $125,000 | – | 36,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
| CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
| Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
| Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
| WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
| D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
| Creative Planning | 56,234 | $172,000 | 0.00% |